Aquestive Therapeutics Inc

XNAS:AQST

6.21

-0.11 (-1.74%)

7:24:33 PM EDT: $6.26 +0.05 (+0.81%)

Market Cap (Intraday)	744.46M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$13.34 Million
Adjusted EPS	-$0.13

See more estimates

10-Day MA	$6.23
50-Day MA	$6.30
200-Day MA	$4.21

See more pivots

Aquestive Therapeutics Inc Stock, XNAS:AQST

30 Technology Drive, Warren, New Jersey 07059

United States of America

Phone: +1.908.941.1900

Number of Employees: 142

http://www.aquestive.com

Description

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patientsÃ¢â?¬â?¢ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.